Active	Status	Sponsor type	Region	Phase	Filter
8 Active 0 Inactive 8 All	Not yet recruiting Recruiting Enrolling by invitation Active, not recruiting Available No longer recruiting	Industry lead sponsor Industry collaborator Coop Other	US Canada Japan Europe RoW	N/A 1 2 3 4	Highlight changes:- Show only changed items Enrollment:

Advanced Filters

5 Trials

Active Trials   Industry lead sponsorIndustry collaborator

 

Export

Trial + Data / Events	Status	Ph	N	Region	Interventions	Sponsor	Conditions	Primary compl	Study compl
Loges, Sonja
BGBC003, NCT02488408: A Phase Ib/II Multicenter Open-label Study of Bemcentinib (BGB324) in Patients With AML or MDS	Active, not recruiting	1/2	121	Europe, US	Bemcentinib, BGB324, Cytarabine, Ara-C, Decitabine, Dacogen	BerGenBio ASA	Acute Myeloid Leukemia, Myelodysplastic Syndromes	04/22	04/22
CONNECT, NCT05701150: AIO-BNHO Comprehensive Clinico-genomics Database Network - AIO-BNHO	Recruiting	N/A	3000	Europe	Minimal documentation, Extended documentation	AIO-Studien-gGmbH, Daiichi Sankyo Europe, GmbH, a Daiichi Sankyo Company, Merck Sharp & Dohme LLC, Janssen-Cilag G.m.b.H	Advanced Solid Tumor	12/25	12/25
Teufel, Andreas
NCT04595825: CM-101 in PSC Patients -The SPRING Study	Active, not recruiting	2	68	Europe, US, RoW	Anti-human CCL24 monoclonal antibody (CM-101), Placebo	ChemomAb Ltd.	Primary Sclerosing Cholangitis	09/24	09/25
NCT03645980 / 2017-002468-41: DKN-01 Inhibition in Advanced Liver Cancer	Recruiting	1/2	70	Europe	DKN-01 300 mg, DKN-01 600 mg, Sorafenib	Johannes Gutenberg University Mainz, Leap Therapeutics, Inc.	Hepatocellular Carcinoma	08/21	08/22
Janning, Melanie
ANTELOPE, NCT05689671: Pemetrexed-free vs. Pemetrexed-based Immunochemotherapy in Metastatic TTF-1 Negative Lung Adenocarcinoma	Recruiting	4	136	Europe	Atezolizumab, Tecentriq, Nab paclitaxel, Abraxane, Carboplatin, Pembrolizumab, Keytruda, Cisplatin, Pemetrexed	Nikolaj Frost MD, Roche Pharma AG, Institut für Klinische Krebsforschung IKF GmbH at Krankenhaus Nordwest	Non-Small Cell Lung Cancer Metastatic	10/25	10/26